VirtualScopics, Inc. Schedules 2015 Fourth Quarter And Full Year Financial Results Press Release, Conference Call And Webcast

Feb 29, 2016, 13:00 ET from VirtualScopics, Inc.

ROCHESTER, N.Y., Feb. 29, 2016 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that it will report its 2015 fourth quarter and full year financial results before the markets open on Wednesday, March 30, 2016.  Eric T. Converse, president and chief executive officer, and Jim Groff, chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a business update at 8:30 a.m. ET that morning.  The conference call and webcast information are as follows:

Domestic Call Dial In:  877-407-8035

International Call Dial In:  201-689-8035

Conference Call ID:  13631781

An accompanying slide presentation to enhance managements' formal remarks, as well as a webcast of the call, can be accessed at the following links:

A replay and slide presentation will be available one hour after the conclusion of the conference call for 90 days, and can be accessed accordingly:

Replay Domestic Dial In:  877-660-6853

Replay International Dial In:  201-612-7415

Replay Conference Call ID:  13631781

The webcast and slide presentation can be accessed at the following links:

About VirtualScopics, Inc. VirtualScopics, Inc. (NASDAQ: VSCP) is a leading imaging CRO/Central reader, providing clinical trial imaging solutions to accelerate drug development. Medical and scientific expertise, operational flexibility and responsiveness are hallmarks of our daily work and collaborative approach. We understand the risks and time constraints that clinical trial study teams, medical directors, radiologists, and imaging scientists face. We focus on addressing these challenges by consistently delivering quality imaging data and imaging services on time and within budget. It's these exceptional performance advantages that truly set our clinical trial imaging services apart. For more information about VirtualScopics, Inc., please visit

Forward-looking Statements The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of the Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby.  These forward-looking statements include, but are not limited to, statements regarding continued positive Adjusted EBITDA, the expected benefits of the Company's investment in infrastructure, sales and marketing efforts, the increase in backlog, awards and bookings and the performance of existing projects and/or statements preceded by, followed by or that include the words "believes", "could", "expects", "anticipates", "estimates", "intends", "plans", "projects", "seeks", or similar expressions.  Forward-looking statements deal with the company's current plans, intentions, beliefs and expectations.  Investors are cautioned that all forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements.  Many of these risks and uncertainties are discussed in the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2014 filed with the Securities and Exchange Commission (the "SEC"), and in any subsequent reports filed with the SEC, all of which are available at the SEC's website at  These include without limitation: the risk of cancellation or delay of customer contracts or that contract awards do not turn into signed contracts.  Other risks include the company's dependence on its largest customers and risk of contract performance, protection of our intellectual property and the risks of infringement on the intellectual property rights of others.  All forward-looking statements speak only as of the date of this press release and the company undertakes no obligation to update such forward-looking statements.

For More Information, Contact: Donna N. Stein, APR, Fellow PRSA Managing Partner Donna Stein & Partners 315-361-4672 Email:

SOURCE VirtualScopics, Inc.